BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33464184)

  • 1. Molecular Imaging Approaches in Dementia.
    Villemagne VL; Barkhof F; Garibotto V; Landau SM; Nordberg A; van Berckel BNM
    Radiology; 2021 Mar; 298(3):517-530. PubMed ID: 33464184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular neuroimaging in degenerative dementias.
    Jiménez Bonilla JF; Carril Carril JM
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):301-9. PubMed ID: 23933381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia spectrum disorders: lessons learnt from decades with PET research.
    Wilson H; Pagano G; Politis M
    J Neural Transm (Vienna); 2019 Mar; 126(3):233-251. PubMed ID: 30762136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
    Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET approaches for diagnosis of dementia.
    Ishii K
    AJNR Am J Neuroradiol; 2014; 35(11):2030-8. PubMed ID: 23945233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET radiotracers for molecular imaging in dementia.
    Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
    Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid imaging.
    Villemagne VL; Rowe CC
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S41-9. PubMed ID: 21729418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Dementia With Lewy Bodies.
    Cousins O; Yousaf T; Wilson H; Pagano G; Politis M
    Int Rev Neurobiol; 2019; 144():59-93. PubMed ID: 30638457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of positron emission tomography/computed tomography in dementia.
    Hinds SR; Stocker DJ; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):927-34. PubMed ID: 24010914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging of Diseases Causing Dementia.
    Masdeu JC
    Neurol Clin; 2020 Feb; 38(1):65-94. PubMed ID: 31761062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECT radiopharmaceuticals for dementia.
    Guidotti C; Farioli D; Gaeta MC; Giovannini E; Lazzeri P; Meniconi M; Ciarmiello A
    Curr Radiopharm; 2013 Dec; 6(4):192-207. PubMed ID: 24359135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Imaging and Precision Medicine in Dementia and Movement Disorders.
    Mallik AK; Drzezga A; Minoshima S
    PET Clin; 2017 Jan; 12(1):119-136. PubMed ID: 27863563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of PET neuroimaging.
    Nasrallah I; Dubroff J
    Semin Nucl Med; 2013 Nov; 43(6):449-61. PubMed ID: 24094712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New PET markers for the diagnosis of dementia.
    Payoux P; Salabert AS
    Curr Opin Neurol; 2017 Dec; 30(6):608-616. PubMed ID: 28906268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression.
    Conte M; De Feo MS; Corica F; Gorica J; Sidrak MMA; De Cristofaro F; Filippi L; Ricci M; De Vincentis G; Frantellizzi V
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT and PET imaging in Alzheimer's disease.
    Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
    Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.